" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...

The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy ... With this chart, I'd like to take a moment to address recent developments in China, which, of course, have been ...

“If requested we will fully cooperate with the authorities.” AstraZeneca last week said its China head, Leon Wang, was ...

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...

London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

AstraZeneca (AZN) said it plans to spend $3.5B to expanding its research and manufacturing capabilities in the United States ...

British drugmaker AstraZeneca increased its full-year sales outlook on booming demand for its cancer and rare-disease drugs, and said it plans to invest $3.5 billion in its U.S. business by the end of ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca has announced a $3.5 billion investment in expanding its research and manufacturing ...

Reports Q3 revenue $13.57B, consensus $13.09B. Reports Q3 core EPS $2.08. Pascal Soriot, CEO, AstraZeneca (AZN), said: “Our company has continued on its strong growth trajectory in the first nine ...

Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the ...